XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-based Compensation
12 Months Ended
Dec. 31, 2020
Stock-based Compensation  
8- Stock-based Compensation

(8) Stock-based Compensation

 

At December 31, 2020, we had one stock-based compensation plan that is described below. We account for our plan under ASC 718, and the disclosures that follow are based on applying ASC 718.

 

Our Amended and Restated 2006 Equity Incentive Plan, or 2006 Plan, provides for awards to key employees, non-employee directors and consultants of incentive and nonqualified stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance shares and other stock-based awards. Under the 2006 Plan, 200,000 shares, in the aggregate, of common stock were reserved for awards. The purchase price of shares issued on the exercise of options were required to be at least equal to the fair market value of such shares on the date of grant. The options granted become exercisable and expire as determined by the Compensation Committee. As of December 31, 2020, no future stock-based awards were permitted under the 2006 Plan.

A summary of stock option transactions for the year ended December 31, 2020, is presented below: 

 

 

Options

 

Shares

 

 

Weighted Average Exercise Price

 

 

Weighted

Average Remaining Contractual

Term

 

Outstanding at December 31, 2019

 

 

20,000

 

 

$501.03

 

 

2.3 years

 

Granted

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

20,000

 

 

$501.03

 

 

1.3 years

 

Exercisable at December 31, 2020

 

 

12,000

 

 

$501.03

 

 

1.3 years

 

All nonvested options outstanding at December 31, 2020 are expected to vest. None of our grants includes performance-based or market-based vesting conditions. We estimate the fair value of stock options granted using the Black-Scholes option-pricing formula and a single option award approach. Our Black-Scholes valuation uses a volatility factor based on our historical stock trading history, a risk-free interest rate based on the implied yield currently available on U.S. Treasury securities with an equivalent term, and a dividend yield based on our dividend history. Our expected life assumption represents the period that our stock-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior.

 

There were no options granted in 2020 and 2019.

 

The weighted average grant date fair value of the options granted in 2017 was $130.35. The total intrinsic value of options outstanding at December 31, 2020, was $2.8 million. The total intrinsic value of exercisable options at December 31, 2020, was $1.7 million.

 

There were no restricted stock grants during 2020 and 2019. During 2017, we granted two awards of restricted stock under the 2006 Plan. Under the terms of our restricted stock awards, the restrictions usually lapse over a five-year period. Both awards include restrictions on transfer for a two-year period following vesting. During the vesting period, holders of restricted stock have voting rights and earn dividends, but the shares may not be sold, assigned, transferred, pledged or otherwise encumbered. Nonvested shares are generally forfeited on termination of employment unless otherwise provided in the participant’s employment agreement or the termination is in connection with a change in control. We calculated the weighted average fair value per share of the restricted stock awarded in 2017 using the market value of our common stock on the date of the grant with a discount for post-vesting restrictions of 11.2%. We estimated this discount using the Chaffe protective put method. A summary of changes in nonvested restricted stock for the year ended December 31, 2020, is presented below: 

 

Nonvested Shares

 

Shares

 

 

Weighted Average Award Date Fair Value Per Share

 

Restricted stock at December 31, 2019

 

 

3,540

 

 

$445.47

 

Granted in 2020

 

 

 

 

 

 

Vested in 2020

 

 

(1,180)

 

$445.47

 

Restricted stock at December 31, 2020

 

 

2,360

 

 

$445.47

 

During 2020, restricted stock units were added to certain employee accounts under the 2006 Plan as dividend equivalents. All of our restricted stock units granted under the 2006 Plan are convertible to shares of stock on a one-for-one basis when the restrictions lapse, which is generally after a five-year period. Nonvested restricted stock units are generally forfeited on termination of employment unless the termination is in connection with a change in control. During the vesting period, holders of restricted stock units earn dividends in the form of additional units. During 2020, one non-employee director elected to receive stock units in lieu of a portion of his cash fees for his services as a member of the Board of Directors.

 

A summary of changes in stock units for the year ended December 31, 2020, is presented below:  

 

 

Nonvested Stock Units

 

Restricted

Stock Units

 

 

Weighted

Average

Award Date

Fair Value

Per Unit

 

 

Director’s

Stock Units

 

 

Weighted

Average

Award Date

Fair Value

Per Unit

 

Nonvested at December 31, 2019

 

 

3,601

 

 

$623.19

 

 

 

 

 

 

 

Added

 

 

33

 

 

$635.04

 

 

 

16

 

 

$711.75

 

Forfeited

 

 

(40)

 

$766.48

 

 

 

 

 

 

 

 

Vested

 

 

(479)

 

$388.02

 

 

 

(16)

 

$711.75

 

Nonvested at December 31, 2020

 

 

3,115

 

 

$657.70

 

 

 

 

 

 

 

 

All nonvested restricted stock units set forth above at December 31, 2020 are expected to vest. The total intrinsic value of these outstanding stock units which were not convertible at December 31, 2020, including 503 stock units held for the accounts of non-employee directors, was $2,324,000. The total fair value of directors’ stock units that vested during 2020, 2019 and 2018 was $11,000, $7,000 and $6,000, respectively.

 

In addition to the above, during 2020 we granted 3,865 restricted stock units to three employees outside of the 2006 Plan that will be settled in cash and are treated as liability-classified awards. The grant-date fair value per unit for these awards was $646.90. No grants of this type were made outside the 2006 Plan prior to 2020. These units will vest 20 percent each year over a five-year period beginning in 2021. Changes in the fair value of these awards are recorded to G&A expense over the vesting period of the award. The liability recorded for these units is adjusted to the current market value at the end of each reporting period. At December 31, 2020, none of these units had vested and our recorded liability for these units was $250,000. The intrinsic value of these units at December 31, 2020 was $2,496,000 including accrued amounts for dividend equivalents.

 

There were no stock awards to nonemployee directors under the 2006 Plan in 2020. The total value of stock awards to nonemployee directors awarded under the 2006 Plan was $240,000 in each of 2019 and 2018. These awards vested immediately at the time of the grants. Compensation related to stock awards, restricted stock and stock units that are treated as equity-classified awards is based on the fair market value of the stock on the date of the award. These fair values are then amortized on a straight-line basis over the requisite service periods of the entire awards, which is generally the vesting period. Compensation related to stock options is based on the fair value of stock options granted using the Black-Scholes option-pricing formula and a single option award approach.

 

For the years ended December 31, 2020, 2019 and 2018, we recorded stock-based compensation expense as a G&A expense in the amount of $1,731,000, $1,682,000 and $1,659,000, respectively, for all of the above-mentioned stock-based compensation arrangements. The total tax benefit recognized in the income statement from stock-based compensation arrangements for the years ended December 31, 2020, 2019 and 2018 was $444,000, $765,000 and $441,000, respectively. These amounts include excess tax benefits in each year.

Unrecognized compensation cost information for our various stock-based compensation awards is shown below as of December 31, 2020:  

 

 

 

 

Unrecognized

Compensation

Cost

 

 

Weighted Average

Remaining Years

in Amortization

Period

 

Stock options

 

$682,000

 

 

 

1.3

 

Restricted stock

 

 

687,000

 

 

 

1.3

 

Restricted stock units

 

 

990,000

 

 

 

2.8

 

Restricted stock units (to be settled in cash)

 

 

2,246,000

 

 

 

4.5

 

Total

 

$4,605,000

 

 

 

 

 

We have a policy of utilizing treasury shares to satisfy stock option exercises, stock unit conversions and restricted stock awards that are equity-classified awards.